Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer
The pulmonary route for drug administration has garnered a great deal of attention in therapeutics for treating respiratory disorders. It allows for the delivery of drugs directly to the lungs and, consequently, the maintenance of high concentrations at the action site and a reduction in systemic ad...
Saved in:
Main Authors: | Raquel Fernández-García, Ana I. Fraguas-Sánchez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/12/1584 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation
by: Ruwani K. Suraweera, et al.
Published: (2024-11-01) -
Evaluation of Inhaler Technique in Patients with Asthma and Chronic Obstructive Pulmonary Disease in Andaman and Nicobar Islands – An Observational Study
by: M. Natraj, et al.
Published: (2025-01-01) -
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
by: Wenjun Meng, et al.
Published: (2024-12-01) -
Biopolymeric Inhalable Dry Powders for Pulmonary Drug Delivery
by: Sara E. Maloney Norcross, et al.
Published: (2024-12-01) -
A novel multi-drugs ciprofloxacin-curcumin-N-acetylcysteine co-delivery system based on hybrid nanocrystals for dry powder inhalations
by: Yingying Ma, et al.
Published: (2024-01-01)